| No | 1 | Date of announcement | 2021/03/31 | Time of announcement | 20:49:25 |
|---|---|---|---|---|---|
| Subject | An Indian patent on the Anti-CεmX (FB825) antibody was granted. | ||||
| To which item it meets |
paragraph 53 | Date of events | 2021/03/31 | ||
| Statement | |||||
|
1.Date of occurrence of the event:2021/04/03
2.Company name:ONENESS BIOTECH CO., LTD. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office 4.Reciprocal shareholding ratios:NA 5.Cause of occurrence:FB825, anti-CεmX antibody, has been granted an Indian patent titled“ANTI-CεMX ANTIBODIES CAPABLE OF BINDING TO HUMAN MIGE ON B LYMPHOCYTES”under the patent number 361876. 6.Countermeasures:None 7.Any other matters that need to be specified:The assignee of the above-mentioned patent is Academia Sinica. Oneness Biotech owns the exclusive worldwide right of the patent for manufacture, use, and sale of the product. |
|||||
